These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 8712071)

  • 1. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.
    Hall M; Peters G
    Adv Cancer Res; 1996; 68():67-108. PubMed ID: 8712071
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
    Lee YM; Sicinski P
    Cell Cycle; 2006 Sep; 5(18):2110-4. PubMed ID: 16969111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16INK4 mutations and altered expression in human tumors and cell lines.
    Okamoto A; Demetrick DJ; Spillare EA; Hagiwara K; Hussain SP; Bennett WP; Forrester K; Gerwin B; Greenblatt MS; Serrano M
    Cold Spring Harb Symp Quant Biol; 1994; 59():49-57. PubMed ID: 7587103
    [No Abstract]   [Full Text] [Related]  

  • 6. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
    Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
    J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
    Vikhanskaya F; Erba E; D'Incalci M; Broggini M
    Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
    Hunter T; Pines J
    Cell; 1994 Nov; 79(4):573-82. PubMed ID: 7954824
    [No Abstract]   [Full Text] [Related]  

  • 10. Staurosporine-induced growth inhibition of glioma cells is accompanied by altered expression of cyclins, CDKs and CDK inhibitors.
    Harmalkar MN; Shirsat NV
    Neurochem Res; 2006 May; 31(5):685-92. PubMed ID: 16770740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex.
    Ellis M; Chew YP; Fallis L; Freddersdorf S; Boshoff C; Weiss RA; Lu X; Mittnacht S
    EMBO J; 1999 Feb; 18(3):644-53. PubMed ID: 9927424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
    Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclins and related kinases in cancer cells.
    Malumbres M
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer.
    Musgrove EA; Lilischkis R; Cornish AL; Lee CS; Setlur V; Seshadri R; Sutherland RL
    Int J Cancer; 1995 Nov; 63(4):584-91. PubMed ID: 7591270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus.
    Altucci L; Addeo R; Cicatiello L; Germano D; Pacilio C; Battista T; Cancemi M; Petrizzi VB; Bresciani F; Weisz A
    Endocrinology; 1997 Mar; 138(3):978-84. PubMed ID: 9048598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How cells cycle toward cancer.
    Marx J
    Science; 1994 Jan; 263(5145):319-21. PubMed ID: 8278804
    [No Abstract]   [Full Text] [Related]  

  • 17. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
    Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
    Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
    Wilcken NR; Sarcevic B; Musgrove EA; Sutherland RL
    Cell Growth Differ; 1996 Jan; 7(1):65-74. PubMed ID: 8788034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.
    Sgambato A; Han EK; Zhang YJ; Moon RC; Santella RM; Weinstein IB
    Carcinogenesis; 1995 Sep; 16(9):2193-8. PubMed ID: 7554074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-cycle regulators and cancer.
    Kamb A
    Trends Genet; 1995 Apr; 11(4):136-40. PubMed ID: 7732591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.